ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,702.55
      -0.19%
      US Tech 100
      19,310.00
      0.06%
      Dow Jones
      42,063.36
      0.00%
      Brent Oil
      74.135
      0.34%
      Bitcoin
      63,413.85
      -0.33%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Castle Biosciences Inc (CSTL) Quote

      Castle Biosciences Inc

      Castle Biosciences Inc (CSTL)

      NASDAQ
      31.47
      0.94
      (3.08%)
      Closed September 20 4:00PM
      Delayed by 15 minutes
      31.47
      0.00
      ( 0.00% )
      Pre Market: 7:39AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      31.47
      Bid
      31.47
      Ask
      32.50
      Volume
      1
      0.00 Day's Range 0.00
      12.07 52 Week Range 32.53
      Market Cap
      872.876M
      Previous Close
      31.47
      Open
      -
      Last Trade
      1
      @
      31.1
      Last Trade Time
      05:20:26
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      428,495
      Shares Outstanding
      27,736,760
      Dividend Yield
      -
      PE Ratio
      -15.19
      Earnings Per Share (EPS)
      -2.07
      Revenue
      219.79M
      Net Profit
      -57.47M

      About Castle Biosciences Inc

      Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanom... Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others. Show more

      Sector
      Medical Laboratories
      Industry
      Medical Laboratories
      Website
      www.castlebiosciences.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Castle Biosciences Inc is listed in the Medical Laboratories sector of the NASDAQ with ticker CSTL. The last closing price for Castle Biosciences was $31.47. Over the last year, Castle Biosciences shares have traded in a share price range of $ 12.07 to $ 32.53.

      Castle Biosciences currently has 27,736,760 shares outstanding. The market capitalization of Castle Biosciences is $872.88 million. Castle Biosciences has a price to earnings ratio (PE ratio) of -15.19.

      Ask ADVFN Intelligence (AI)

      Castle Biosciences (CSTL) Options Flow Summary

      CSTL Options Flow

      Overall Flow

      Bullish

      Net Premium

      225k

      Calls / Puts

      100.00%

      Buys / Sells

      0.00%

      OTM / ITM

      25.00%

      Sweeps Ratio

      0.00%

      CSTL Latest News

      More News

      New Data at AFS 2024 Demonstrates the Strength of Castle Biosciences’ TissueCypher® Test in Independently Predicting Risk of Developing Esophageal Cancer, Guiding Risk-Aligned Management Decisions for Patients with Barrett’s Esophagus

      Oral abstract will share data showing that TissueCypher alone, compared to combining the test’s results with a patient’s clinicopathologic risk factors, like age and pathology diagnosis, is the...

      56 minutes ago
      Business Wire

      Castle Biosciences’ Chief Operating Officer Kristen Oelschlager Named Arizona Bioscience Leader of the Year

      The Arizona Bioindustry Association, Inc. (AZBio) and Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that...

      September 16 2024
      Business Wire

      DecisionDx®-Melanoma Can Identify Melanoma Patients with Low Risk of Sentinel Lymph Node Positivity Who May Safely Forego Biopsy Surgery, New Independent Study Affirms

      Using the DecisionDx-Melanoma test to guide sentinel lymph node biopsy (SLNB) surgery decisions could have significantly reduced the number of unnecessary SLNBs by 33% for patients with T1-T2...

      September 11 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      September 05 2024
      Edgar (US Regulatory)

      Study Confirms the Ability of Castle Biosciences' DecisionDx®-SCC Test to Predict Likelihood of Benefit from Adjuvant Radiation Therapy in Patients with High-Risk Cutaneous Squamous Cell Carcinoma

      This is the second study to demonstrate the ability of the DecisionDx-SCC test to identify patients who are more or less likely to benefit from adjuvant radiation therapy (ART), confirmed in an...

      September 05 2024
      Business Wire

      Castle Biosciences to Participate in Upcoming Investor Conferences

      Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that its executive management is scheduled to present a...

      August 28 2024
      Business Wire

      Form 4 - Statement of changes in beneficial ownership of securities

      August 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 13 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 13 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.371.1897106109331.132.5329.9947682030.97143199CS
      41.545.1453391246229.9332.5328.433887830.14616653CS
      129.8345.425138632221.6432.5316.96542849524.9321729CS
      2611.3556.411530815120.1232.5316.96532579424.03173871CS
      5214.8188.895558223316.6632.5312.0729433321.87228295CS
      156-44.42-58.532085913875.8976.029.260130029124.30099911CS
      2608.7538.512323943722.72107.699.260126259033.77037349CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      NVVENuvve Holding Corporation
      $ 7.10
      (81.12%)
      		4.37M
      SOXMTradr 2X Long SOXX Monthly ETF
      $ 36.96
      (58.98%)
      		57
      NUKKNukkleus Inc
      $ 0.326
      (53.41%)
      		19.53M
      BDTXBlack Diamond Therapeutics Inc
      $ 7.07
      (48.53%)
      		3.71M
      XPONExpion360 Inc
      $ 0.125
      (47.41%)
      		6.25M
      PRFXPainReform Ltd
      $ 0.589
      (-23.62%)
      		47.48k
      ZJYLJin Medical International Ltd
      $ 3.18
      (-22.06%)
      		43.94k
      AACGATA Creativity Global
      $ 0.40
      (-21.61%)
      		1
      SMXTSolarMax Technology Inc
      $ 0.7029
      (-19.75%)
      		250
      CJETChijet Motor Company Inc
      $ 2.28
      (-18.57%)
      		849
      NUKKNukkleus Inc
      $ 0.326
      (53.41%)
      		19.53M
      LGCBLinkage Global Inc
      $ 0.5516
      (31.87%)
      		12.82M
      XPONExpion360 Inc
      $ 0.125
      (47.41%)
      		6.25M
      MAXNMaxeon Solar Technologies Ltd
      $ 0.0837
      (-8.52%)
      		4.53M
      NVVENuvve Holding Corporation
      $ 7.10
      (81.12%)
      		4.37M

      Discussion

      View Full Feed
      mzasif mzasif 2 minutes ago
      $BNCM >> Huge **Pharma Acquisition** NEWS OUT! $1++ coming! Next FCCN / FZRO type run here >> multiple dollars baby!
      BNCM: DELEX Acquisition of JMN BROTHERS PHARMA will fuel its Market Growth
      https://www.otcmarkets.com/stock/BNCM/news/BNCM-DELEX-Acquisition-of-JMN-BROTHERS-PHARMA-will
      BNCM FCCN FZRO
      Walshballs Walshballs 2 minutes ago
      Also nothing the ir guy has posted has come true either and that’s a source directly tied to the company. 3-5 days until funding back in March. Green bond coming after Ramadan. A deal with an oil and gas company coming soon posted back at the end of 2023 and I could go on.
      CLNV
      SCAMBUSTERKING SCAMBUSTERKING 2 minutes ago
      Jakey likes to pretend to be a good trader/investor, but he's not. In previous disclosures Jake had to admit to losing a significant amount of the company's cash... now you can watch him pump LPA for a 50% loss:

      http://www.stocktwits.com/sunsettradinggroup

      Absolutely hi
      BCAP LPA
      1vman 1vman 3 minutes ago
      *****🅰️🅰️🅰️ These spin offs rarely amount to anything in the way of shareholder value

      ENOUGH SAID
      HCWC
      Pisd Pisd 3 minutes ago
      Added the little dump..89, .86, let's GOOOO!... VFF$...
      VFF
      linkvest linkvest 3 minutes ago
      That is why I don't even look under the hood anymore. My Caddy and Vette's engine doesn't even look like engines. They look like components of a space age rocket. Last time I worked on my own car is when I couldn't find the distributor cap to replace the rotor and cap. Then I found out that they don
      IGPK
      starkd748 starkd748 3 minutes ago
      Dems won't kill it but Reps would be better in the near term....What's crazy is I don't think it matters big boys are here now so we are at their misery.....It's best to get this gains before we go in a bear cycle and re accumulate
      NewBornTrade NewBornTrade 4 minutes ago
      About $RONN

      135M shares added in 2 weeks
      RONN
      tw0122 tw0122 4 minutes ago
      Back in 4.36. Article explains why Americans barely making it..
      Why App-Based Jobs Don't Pay Like They Used To

      Tyler Durden's Photo
      BY TYLER DURDEN
      MONDAY, SEP 23, 2024 - 05:00 AM
      Authored by Austin Alonzo via The Epoch Times (emphasis ours),
      UVIX
      Welcome2Pinkyland Welcome2Pinkyland 4 minutes ago
      $TAMG FOR THE WIN $$
      TAMG
      CaptainObvious CaptainObvious 5 minutes ago
      Do they still report the numbers of people under treatment in their quarterlies? Has it grown, or is it still around 3,500(?) ?
      NWBO
      PegnVA PegnVA 5 minutes ago
      Trump says he won't run for the presidency again if he loses in November
      Story by abharade@insider.comhttps://www.msn.com/en-us/news/politics/trump-says-he-won-t-run-for-the-presidency-again-if-he-loses-in-november/ar-AA1r1yda?ocid=BingNewsSerp

      In the past, TFG's response alway
      goodietime goodietime 6 minutes ago
      Dated April 22, 2004,
      LEHNQ
      StayHumble StayHumble 6 minutes ago
      @healthiercmc Local🟩Organic🟩Fresh🟩3 words Healthy Choice Markets! $HCMC $HCWC


      -🟩Ada’s Natural Market

      -🟩Paradise Health & Nutrition

      -🟩Mother Earth’s Storehouse

      -🟩Green’s Natural
      HCMC HCWC
      moola26 moola26 6 minutes ago
      Non shareholders broken record posts for 6 years 24/7 have had zero impact on shareholders. We hold and hold strong. No one gave up their shares!!
      MAJORITY HOLDING STRONG$$$
      Milesblue42 Milesblue42 7 minutes ago
      Savannah-Marc, Ronn Ford Diluting again 1,496,787,746 Outstanding Shares

      Some of you people have bad investigating skills. RONN won't release an S-1 until they release around the same time a PR that expresses how much the company is valued at based on the finalization of a deal or de
      RONN
      boraborak38 boraborak38 7 minutes ago
      I knew Teoxane was going to be an issue on this acquisition the second it was announced. Not sure how this plays out though.
      RVNC
      Jack_Bolander Jack_Bolander 7 minutes ago
      B_B - No mention of PLUG.

      Nothing to do with Plug.
      PLUG
      Sltan Sltan 7 minutes ago
      Coming up coming news
      RNVA Foxo RNVA Foxo RNVA
      RNVA
      tw0122 tw0122 7 minutes ago
      Eddie Doyle, 36, a writer and content creator in the Philadelphia area who is mostly retired from driving for Uber and Lyft, said that on balance, most workers whose gig involves driving are probably actually losing money due to fuel expenses and the deterioration of their vehicles.

      D
      UBER
      carlson carlson 7 minutes ago
      Good Morning!
      NBRI
      reena969 reena969 8 minutes ago
      My apologies, I understand what's happening now. I'll stay quiet.

      Happy Trading
      EnchantedTitan62 EnchantedTitan62 8 minutes ago
      5 yrs ago this was @ $20/share, 1 yr ago it was @4/ share, now it's @1& change. Have a wonderful week !
      MYNA
      exwannabe exwannabe 9 minutes ago
      My understanding is that NICE performs its analysis after approval. Otherwise, they would be needlessly evaluating many drugs that don't get approval.
      MHRA says otherwise.

      It is a long process, and they want the guidance as soon as possible after the MHRA action, especially fo
      NWBO

      Your Recent History

      NASDAQ
      CSTL
      Castle Biosciences
      Delayed Upgrade Clock